Related Experiment Video

Updated: Jun 13, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

The genetic basis of kidney cancer: a metabolic disease

W Marston Linehan1, Ramaprasad Srinivasan, Laura S Schmidt

  • 1Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892-1107, USA. wml@nih.gov <wml@nih.gov>

Nature Reviews. Urology
|May 8, 2010
PubMed

Insights

Kidney cancer involves multiple types, each linked to specific genes regulating cell metabolism. Targeting these metabolic pathways offers a promising therapeutic strategy for kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Research

Background:

  • Kidney cancer encompasses diverse subtypes, each with unique genetic origins, histology, and clinical behavior.
  • Seven key genes (VHL, MET, FLCN, TSC1, TSC2, FH, SDH) are implicated in kidney cancer development.
  • These genes are integral to cellular pathways sensing metabolic stress and nutrient availability.

Purpose of the Study:

  • To elucidate the role of specific genes in kidney cancer pathogenesis.
  • To investigate the connection between genetic mutations and cellular metabolic dysregulation in kidney cancer.
  • To explore metabolic pathways as potential therapeutic targets for kidney cancer.

Main Methods:

  • Analysis of genetic mutations in seven known kidney cancer genes.
  • Examination of the involvement of these genes in cellular oxygen, iron, energy, and nutrient sensing pathways.
  • Review of signaling cascades including VHL-HIF, HGF-MET-AMPK, FLCN-AMPK, and mTOR pathways.
  • Assessment of the role of FH and SDH in the mitochondrial tricarboxylic acid cycle.

Main Results:

  • Mutations in kidney cancer genes disrupt metabolic pathways controlling oxygen, iron, energy, and nutrient sensing.
  • VHL protein regulates hypoxia-inducible factor (HIF) in response to oxygen and iron.
  • MET, FLCN, TSC1/2, FH, and SDH are involved in cellular energy and nutrient metabolism.
  • Dysregulation of these metabolic pathways suggests kidney cancer is fundamentally a metabolic disease.

Conclusions:

  • Kidney cancer is characterized by dysregulated cell metabolism due to mutations in specific genes.
  • Targeting the identified metabolic abnormalities presents a novel therapeutic avenue for kidney cancer.
  • Understanding the metabolic basis of kidney cancer can lead to more effective treatments.

More Related Videos

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...